BRAF and infantile convulsions and choreoathetosis: Robertson and colleagues [77] identified, by using immunohistochemistry (IHC), BRAF mutations in 7.4% of iCCA patients, with a longer OS in wild-type patients than in BRAF-mutated subjects (37.3 and 13.5 months, respectively).